196 related articles for article (PubMed ID: 24081644)
1. Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy.
Kukuk GM; Mürtz P; Träber F; Meyer C; Ullrich J; Gieseke J; Ahmadzadehfar H; Ezziddin S; Schild HH; Willinek WA
Eur Radiol; 2014 Feb; 24(2):267-76. PubMed ID: 24081644
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single Center Analysis.
Pieper CC; Sprinkart AM; Meyer C; König R; Schild HH; Kukuk GM; Mürtz P
Medicine (Baltimore); 2016 Apr; 95(14):e3275. PubMed ID: 27057887
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy.
Dudeck O; Zeile M; Wybranski C; Schulmeister A; Fischbach F; Pech M; Wieners G; Rühl R; Grosser O; Amthauer H; Ricke J
Eur Radiol; 2010 Nov; 20(11):2699-706. PubMed ID: 20563725
[TBL] [Abstract][Full Text] [Related]
4. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
[TBL] [Abstract][Full Text] [Related]
6. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization.
Liapi E; Geschwind JF; Vossen JA; Buijs M; Georgiades CS; Bluemke DA; Kamel IR
AJR Am J Roentgenol; 2008 Jan; 190(1):67-73. PubMed ID: 18094295
[TBL] [Abstract][Full Text] [Related]
7. Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with
Weikert T; Maas OC; Haas T; Klarhöfer M; Bremerich J; Forrer F; Sauter AW; Sommer G
Contrast Media Mol Imaging; 2019; 2019():1517208. PubMed ID: 31787860
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study.
Katharina Ingenerf M; Karim H; Fink N; Ilhan H; Ricke J; Treitl KM; Schmid-Tannwald C
Acta Radiol; 2022 Jul; 63(7):877-888. PubMed ID: 34225464
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
[TBL] [Abstract][Full Text] [Related]
10. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
[TBL] [Abstract][Full Text] [Related]
12. Whole-liver diffusion-weighted MRI histogram analysis: effect of the presence of colorectal hepatic metastases on the remaining liver parenchyma.
Lambregts DM; Martens MH; Quah RC; Nikiforaki K; Heijnen LA; Dejong CH; Beets GL; Marias K; Papanikolaou N; Beets-Tan RG
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):399-404. PubMed ID: 25874512
[TBL] [Abstract][Full Text] [Related]
13. Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?
Lavelle LP; O'Neill AC; McMahon CJ; Cantwell CP; Heffernan EJ; Malone DE; Daly L; Skehan SJ
Clin Radiol; 2016 Sep; 71(9):863-8. PubMed ID: 27345612
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor imaging of cysts, hemangiomas, and metastases of the liver.
Erturk SM; Ichikawa T; Kaya E; Yapici O; Ozel A; Mahmutoglu AS; Basak M
Acta Radiol; 2014 Jul; 55(6):654-60. PubMed ID: 24043882
[TBL] [Abstract][Full Text] [Related]
16. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
[TBL] [Abstract][Full Text] [Related]
17. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
Vossen JA; Buijs M; Liapi E; Eng J; Bluemke DA; Kamel IR
J Comput Assist Tomogr; 2008; 32(5):750-6. PubMed ID: 18830105
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
[TBL] [Abstract][Full Text] [Related]
20. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions.
Gourtsoyianni S; Papanikolaou N; Yarmenitis S; Maris T; Karantanas A; Gourtsoyiannis N
Eur Radiol; 2008 Mar; 18(3):486-92. PubMed ID: 17994317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]